This Big Four cannabis stock could nearly double in the next 12 months…
In the legal United States cannabis industry, an industry that sold $20 billion worth of cannabis in 2020 and is expected to reach $45 billion in sales by 2025, you’ll find the “Big Four.”
Those are the heavy hitters of cannabis. They have the most dispensaries in the U.S., are building brands that are becoming household names, and owning shares of these companies now puts you in the best position to profit when cannabis is fully legalized.
To lead off the Big Four, Curaleaf Holdings Inc. (OTC: CURLF) has the most dispensaries (109) in the country and can currently reach an addressable population of 192 million.
In Florida, Trulieve Cannabis Corp. (OTC: TCNNF) accounts for more than 50% of all legal cannabis sold, will be one of the biggest cannabis retailers in Arizona after a key acquisition closes, and is in a race with Curaleaf to see which company will generate $1 billion in sales first.
With 44 retail licenses, over 5,000 product stock-keeping units (SKUs), and more than 900 dispensaries carrying its products, Cresco Labs Inc. (OTC: CRLBF) is right in the mix of being one of the four cannabis companies that should be in every portfolio.
And as for the last member of the Big Four, it’s equally as impressive as the others.
Its three-step strategy is to enter, open, and scale (EOS), and it’s executing that plan to perfection.
It has 62 open dispensaries and 111 retail licenses.
With those 111 retail licenses, it has entered areas of the U.S. where only a limited number of companies can operate but where there is a massive demand for cannabis products.
With the opening of those 62 stores, it’s bringing in consistent revenue, and it just increased year-over-year (YoY) revenue in its latest quarter by 85.4% to $221.9 million.
Now it’s in the scale phase, focusing on its brand becoming a household name for cannabis enthusiasts and building out operations to sell more product across the country.
And on July 7, analysts at Jefferies, the eighth-largest investment bank in the world by revenue, released a bullish $70 price target on this company, which means they see it nearly doubling from its current price tag in the next 12 months. They called this a “generational wealth opportunity.”
For current NICI Membership subscribers, you’ll receive your mailed monthly dossier that has a full S.W.O.T. (Strengths, Weaknesses, Opportunities, Threats) analysis on this final member of the Big Four very soon, and I’ll show you how to receive early access to the online version that is only available to those in NICI Membership in just a moment.
For those who aren’t in NICI Membership, I’ll give you a free preview of why analysts are so bullish on this cannabis stock…
As promised, you can go here now to make sure you’re among the first to receive the exclusive comprehensive dossier on this Big Four company as soon as it drops to all of our NICI Membership subscribers next week.
If you’re already in NICI Membership, you won’t need to lift a finger to have this special dossier hit your inbox next week since you are already a member.
To your investing success,
Executive Director, National Institute for Cannabis Investors
2 responses to “With a Bullish $70 Price Target, This Big Four Cannabis Stock Is Ready to Double Your Money”
August 26 2021